Sa29 Current concepts in the management of submacular hemorrhage in AMD

Web-Seminar, Deutschland
Webinar

Sa29 Current concepts in the management of submacular hemorrhage in AMD

Symposium of the DOG 2020 Online

Datum:
10.10.2020, 18:30 - 10.10.2020, 19:15
Veranstalter:
DOG - Deutsche Ophthalmologische Gesellschaft e.V.
Kurzbeschreibung:
The symposium will summarise what is known about SMH in AMD and discuss a variety of therapeutic interventions including practical skills, techniques, and open questions. Main topics include: established clinical classification of SMH further developed by fundus imaging, Epidemiology, risk factors, and the effect of anti-VEGF monotherapy and many more.
Fortbildungspunkte: 

Fachärzte

Max. Teilnehmer: unbegrenzt
Gebühren ab: 120,00 EUR

Hinweis:
This symposium is part of the DOG congress 2020 (9.-11.2020). The attandance for the total congress costs 250€ for members and 120€ for non-members.

Ärzte/-innen in Weiterbildung

Max. Teilnehmer: unbegrenzt
Gebühren ab: 120,00 EUR

Hinweis:
This symposium is part of the DOG congress 2020 (9.-11.2020). The attandance for the total congress costs 250€ for members and 120€ for non-members.

Studenten/-innen

Max. Teilnehmer: unbegrenzt
Gebühren ab: k.A.

Hinweis:
The full congress is free for students and PhD students.
Bemerkungen:
Diese Veranstaltung findet einmalig statt und bietet Fortbildungsmöglichkeiten für Fachärzte, Ärzte/-innen in Weiterbildung und Studenten/-innen.
Veranstaltungsnummer: 34206
Gebühren ab:  
verfügbare Plätze: unbegrenzt
Sprache: Englisch
 
Vom Veranstalter gemeldetes Programm:

 

18:30 – 18:36

Sa29-01 - A revised classification of submacular haemorrhage using ocular imaging is helpful in clinical decision making

Referent/in: Silvia Bopp, Bremen

18:36 – 18:42

Sa29-02 - Epidemiology and risk factors of submacular hemorrhage in AMD and anti-VEGF monotherapy

Referent/in: Nicolas Feltgen, Göttingen

The epidemiological data of submacular hemorrhage are presented, additionally the spontaneous course and efficacy of anti-VEGF monotherapy.

18:42 – 18:48

Sa29-03 - Reducing risks in the management of macular hemorrhage - minimally invasive and digitally assisted surgical approaches

Referent/in: Lars-Olof Hattenbach, Ludwigshafen

18:48 – 18:54

Sa29-04 - Autologous RPE-choroid patch translocation for large submacular hemorrhages in AMD: evolution of an established surgical technique

Referent/in: Grazia Pertile, Verona, Italy

18:54 – 19:00

Sa29-05 - TIGER: a pan-European randomized clinical trial investigating treatment of submacular hemorrhage in AMD

Referent/in: Jost Hillenkamp, Würzburg

The TIGER study is a 65 centre non-commercial pan-European randomized clinical trial funded by Euretina and supported by Bayer investigating treatment of submacular hemorrhage in AMD. The aim is to study safety and efficacy of vitrectomy, sub-retinal TPA and gas for submacular haemorrhage due to wet AMD followed by intravitreal application of aflibercept compared to treatment with intravitreal aflibercept alone.

19:00 – 19:15

Sa29-06 - Diskussion

Veranstaltungsort:
This symposium is virtual.
Saal von Graefe
Anschrift:

Web-Seminar, Deutschland
Veranstalter:
DOG - Deutsche Ophthalmologische Gesellschaft e.V.
Organisation:

INTERPLAN AG
Congress, Meeting & Event Management AG
Landsberger Straße 155
DE - 80687 München
Tel.: +49 (0)89 548 234 35
Tel.: +49 (0)89 548 234 0
Fax: +49 (0)89 548 234 43
Fax: +49 (0)89 548 234 44

Chairman

Jost Hillenkamp, Würzburg
Lars-Olof Hattenbach, Ludwigshafen
 
Hinweis:

Please contact the roganizer for further information.